| |
| |
|
| Insider
Information: |
Evans Daron |
| Relationship: |
|
| City: |
Berkeley |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
269,718 |
|
|
Indirect Shares
|
60,269 |
|
|
| Direct
Value |
$765,828 |
|
|
|
Indirect Value
|
$243,046 |
|
|
| Total
Shares |
329,987 |
|
|
| Total
Value |
$1,008,874 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
6
|
0
|
|
Stock
price went up :
|
6
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
6.0
|
0.0
|
| Percentage
Gain/Loss : |
 119.8%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Capricor Therapeutics |
CAPR |
Chief Financial Officer |
2009-07-07 |
14,152 |
2009-07-07 |
9,600 |
Premium* |
|
|
Nephros Inc |
NEPH |
CEO Specialty Renal Pr... |
2021-05-24 |
134,215 |
2021-05-27 |
8,669 |
Premium* |
|
|
Rezolute, Inc |
RZLT |
|
2024-05-29 |
121,351 |
2024-05-29 |
42,000 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
58 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| NEPH |
Nephros Inc |
President and CEO |
• • – |
2016-12-23 |
4 |
A |
$0.00 |
$0 |
D/D |
213,068 |
561,661 |
0 |
- |
|
| NEPH |
Nephros Inc |
President and CEO |
• • – |
2017-03-17 |
4 |
B |
$0.00 |
$0 |
I/I |
83,332 |
41,666 |
2.58 |
- |
|
| NEPH |
Nephros Inc |
President and CEO |
• • – |
2017-03-31 |
4 |
A |
$0.00 |
$0 |
D/D |
17,756 |
579,417 |
0 |
- |
|
| NEPH |
Nephros Inc |
President and CEO |
• • – |
2017-05-18 |
4 |
B |
$0.26 |
$5,738 |
D/D |
22,500 |
601,917 |
2.81 |
- |
|
| NEPH |
Nephros Inc |
President and CEO |
• • – |
2017-05-19 |
4 |
B |
$0.26 |
$1,913 |
D/D |
7,500 |
609,417 |
2.73 |
- |
|
| NEPH |
Nephros Inc |
President and CEO |
• • – |
2017-06-09 |
4 |
B |
$0.26 |
$4,550 |
I/I |
17,500 |
49,166 |
2.58 |
- |
|
| NEPH |
Nephros Inc |
President and CEO |
• • – |
2017-06-12 |
4 |
B |
$0.26 |
$1,030 |
D/D |
3,961 |
613,378 |
2.73 |
- |
|
| NEPH |
Nephros Inc |
President and CEO |
• • – |
2017-08-11 |
4 |
B |
$0.26 |
$18,200 |
D/D |
70,000 |
683,378 |
2.81 |
- |
|
| NEPH |
Nephros Inc |
President and CEO |
• • – |
2017-08-22 |
4 |
B |
$0.25 |
$1,000 |
I/I |
4,000 |
51,166 |
2.58 |
- |
|
| NEPH |
Nephros Inc |
President and CEO |
• • – |
2017-09-05 |
4 |
B |
$0.24 |
$371 |
D/D |
1,580 |
684,958 |
2.73 |
- |
|
| NEPH |
Nephros Inc |
President and CEO |
• • – |
2017-09-06 |
4 |
B |
$0.24 |
$6,818 |
D/D |
28,000 |
712,958 |
2.81 |
- |
|
| NEPH |
Nephros Inc |
President and CEO |
• • – |
2017-12-20 |
4 |
A |
$0.00 |
$0 |
D/D |
180,000 |
892,958 |
0 |
- |
|
| NEPH |
Nephros Inc |
President and CEO |
• • – |
2018-04-10 |
4 |
B |
$0.45 |
$35,550 |
I/I |
79,000 |
63,166 |
2.66 |
- |
|
| NEPH |
Nephros Inc |
President and CEO |
• • – |
2018-05-14 |
4 |
OE |
$0.30 |
$12,000 |
I/I |
40,000 |
95,000 |
0 |
- |
|
| NEPH |
Nephros Inc |
President and CEO |
• • – |
2018-12-14 |
4 |
A |
$0.00 |
$0 |
D/D |
108,296 |
1,001,254 |
0 |
- |
|
| NEPH |
Nephros Inc |
President and CEO |
• • – |
2019-06-14 |
4 |
B |
$0.58 |
$19,078 |
I/I |
32,000 |
8,000 |
2.58 |
- |
|
| NEPH |
Nephros Inc |
President and CEO |
• • – |
2019-06-14 |
4 |
B |
$0.60 |
$6,683 |
D/D |
11,172 |
1,052,426 |
2.81 |
- |
|
| NEPH |
Nephros Inc |
President and CEO |
• • – |
2019-08-22 |
4 |
B |
$6.92 |
$13,845 |
D/D |
2,000 |
118,933 |
2.81 |
- |
|
| NEPH |
Nephros Inc |
President and CEO |
• • – |
2019-11-18 |
4 |
B |
$8.35 |
$8,350 |
D/D |
1,000 |
119,933 |
2.81 |
- |
|
| NEPH |
Nephros Inc |
President and CEO |
• • – |
2019-12-16 |
4 |
A |
$0.00 |
$0 |
D/D |
9,282 |
129,215 |
0 |
- |
|
| NEPH |
Nephros Inc |
President and CEO |
• • – |
2020-03-05 |
4 |
B |
$8.44 |
$21,109 |
D/D |
2,500 |
131,715 |
2.81 |
- |
|
| NEPH |
Nephros Inc |
President and CEO |
• • – |
2020-03-12 |
4 |
B |
$6.65 |
$16,625 |
D/D |
2,500 |
134,215 |
2.81 |
- |
|
| NEPH |
Nephros Inc |
CEO of Specialty Renal Product |
• – – |
2021-05-24 |
4 |
OE |
$2.70 |
$5,999 |
I/I |
2,222 |
9,018 |
0 |
- |
|
| NEPH |
Nephros Inc |
CEO Specialty Renal Products |
• – – |
2021-05-27 |
4/A |
D |
$2.70 |
$1,885 |
I/I |
(698) |
8,669 |
0 |
- |
|
| RZLT |
Rezolute, Inc |
CFO |
• – – |
2024-01-22 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
10,000 |
|
% |
|
58 Records found
|
|
Page 2 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
